Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Stockholders Equity of $954.27 million for fiscal year 2025.
CATALYST PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $954.27M | +31.1% |
| 2024 | $727.63M | +87.6% |
| 2023 | $387.88M | +29.1% |
| 2022 | $300.42M | +45.2% |
| 2021 | $206.83M | +22.0% |
| 2020 | $169.60M | +93.5% |
| 2019 | $87.63M | +72.6% |
| 2018 | $50.78M | -37.3% |
| 2017 | $80.96M | +106.0% |
| 2016 | $39.31M | -29.1% |
| 2015 | $55.48M | +57.4% |
| 2014 | $35.24M | +64.8% |
| 2013 | $21.39M | +46.3% |
| 2012 | $14.62M | +288.8% |
| 2011 | $3.76M | -31.8% |
| 2010 | $5.52M | -27.6% |
| 2009 | $7.62M | -27.9% |
| 2008 | $10.56M | -35.3% |
| 2007 | $16.32M | -17.8% |
| 2006 | $19.85M | +4345.3% |
| 2005 | $446.5K | +279.7% |
| 2004 | $117.6K | -67.6% |
| 2003 | $362.6K | +707.7% |
| 2002 | $44.9K | -55.1% |
| 2001 | $100.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $920.25M | +39.2% | +7.5% |
| June 30, 2025 | $856.03M | +40.6% | +7.8% |
| March 31, 2025 | $794.28M | +41.5% | +9.2% |
| December 31, 2024 | $727.63M | +87.6% | +10.1% |
| September 30, 2024 | $660.94M | +89.6% | +8.6% |
| June 30, 2024 | $608.65M | +62.2% | +8.4% |
| March 31, 2024 | $561.41M | +68.3% | +44.7% |
| December 31, 2023 | $387.88M | +29.1% | +11.3% |
- CATALYST PHARMACEUTICALS, INC. showed an increase of +31.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2001–2025 period, CATALYST PHARMACEUTICALS, INC.’s stockholders equity has grown by 954168.0% (from $100.0 thousand to $954.27 million).
- The most recent figure is from CATALYST PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: